The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.
Multiple local, state and federal agencies are investigating the Jan. 21 death of a California man several hours after receiving the COVID vaccine.
Placer County Sheriff’s office said in a Jan. 23 Facebook post that agencies are “actively investigating this case.” They also mentioned that the man had tested positive for COVID in December. The U.S. Centers for Disease Control and Prevention (CDC) recommends that individuals who have already had COVID and fully recovered should still get vaccinated.
As of Jan. 15, 181 deaths have been reported to the U.S.government’s Vaccine Adverse Events Reporting System as possibly being related to COVID vaccines. A 2010 study by the U.S. Department of Health and Human Services concluded that “fewer than 1% of vaccine injuries” are reported to VAERS and experts say the government’s reporting system is “broken.”
Meanwhile reports of injuries continue to surface in the media, including an article in the Jerusalem Post about a 17-year-old who was hospitalized in the intensive care unit after receiving the second dose of a COVID vaccine. Hospital officials told the Post they did not believe the boy’s illness was related to the vaccine.
Dr. Anthony Fauci told reporters last week that he was “knocked out” after receiving the second dose of the vaccine, but says he feels fine now. Fauci received the first dose of the Moderna vaccine in December on live television to boost the public’s confidence in the vaccine.
Last week, The Defender reported that allergic reactions had caused California health officials to hit pause on a large batch of Moderna vaccines. A few days later, Moderna said it was okay to resume using that batch.
Today, multiple news outlets reported that Merck has ended its COVID-19 vaccine program after early trial data showed the vaccine maker’s two experimental vaccines failed to generate immune responses comparable to a natural infection or existing vaccines. Bloomberg reported:
“The U.S. drug giant, which has a history of successfully developing vaccines, had adopted a different strategy from rivals Pfizer Inc., Moderna Inc. and Johnson & Johnson, using a more traditional approach of focusing on shots based on weakened viruses.”